The Kaplan–Meier survival curves, including the number of elevated biomarkers, showed that patients with both GDF-15 and NT-pro BNP levels above the cut-off point had a significantly higher risk of death or HF rehospitalization at each of the three time points than patients with only one or no elevated biomarkers. This evidence concerns the gene GDF15 and hydrops fetalis.